Melf Sönnichsen - Concepedia

Author

Melf Sönnichsen

Also Known As

M Sönnichsen, M. Sönnichsen, Melf Sönnichsen

Publications

261

Citations

H-Index

Concepts

All Affiliations

Melf Sönnichsen is an author at Heinrich Heine University Düsseldorf specializing in cell death, cancer therapeutics, and cancer research.

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	20
2	Pharmacology	1	1	20
3	Cancer Therapeutics	1	1	20
4	Head And Neck Cancer	1	1	20
5	Apoptosis	1	1	20

Melf Sönnichsen

Publications

242

Citations

H-Index

Page 1

	Year	Citations
Hydroxamic Acids Immobilized on Resins (HAIRs): Synthesis of Dual‐Targeting HDAC Inhibitors and HDAC Degraders (PROTACs) Laura Sinatra, Jan J. Bandolik, Martin Roatsch, Angewandte Chemie International Edition	2020	69
Solid-Phase Synthesis of Cereblon-Recruiting Selective Histone Deacetylase 6 Degraders (HDAC6 PROTACs) with Antileukemic Activity Laura Sinatra, Jing Yang, Julian Schliehe‐Diecks, Journal of Medicinal Chemistry	2022	63
Multicomponent Synthesis, Binding Mode, and Structure–Activity Relationship of Selective Histone Deacetylase 6 (HDAC6) Inhibitors with Bifurcated Capping Groups Nina Reßing, Melf Sönnichsen, J.D. Osko, Journal of Medicinal Chemistry	2020	51
Development of Fluorinated Peptoid-Based Histone Deacetylase (HDAC) Inhibitors for Therapy-Resistant Acute Leukemia Nina Reßing, Julian Schliehe‐Diecks, P. R. Watson, Journal of Medicinal Chemistry	2022	29
Synergistic induction of apoptosis in resistant head and neck carcinoma and leukemia by alkoxyamide-based histone deacetylase inhibitors Leandro A. Alves Avelar, Christian Schrenk, Melf Sönnichsen, European Journal of Medicinal Chemistry Synergistic InductionResistant HeadOncologyOncogenic AgentMedicine	2020	20
Preferential HDAC6 inhibitors derived from HPOB exhibit synergistic antileukemia activity in combination with decitabine Maik Tretbar, Julian Schliehe‐Diecks, Lukas von Bredow, European Journal of Medicinal Chemistry	2024	10

Page 1